Laura E. Niklason - Jun 15, 2023 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
President, CEO and Director, Director, 10%+ Owner
Signature
/s/ Laura E. Niklason by Dale A. Sander as Attorney-in-Fact
Stock symbol
HUMA
Transactions as of
Jun 15, 2023
Transactions value $
$0
Form type
4
Date filed
6/16/2023, 04:09 PM
Previous filing
Jun 15, 2023
Next filing
Aug 21, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUMA Stock Options (right to buy) Award $0 +8.5K $0.00 8.5K Jun 15, 2023 Common Stock 8.5K $3.35 By spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The first 25% of the option becomes exercisable on June 15, 2024, after which 1/48 of the option will become exercisable on the 15th of each month through June 15, 2027.